about
Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.ERCP-induced and non-ERCP-induced acute pancreatitis: Two distinct clinical entities with different outcomes in mild and severe form?Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.Anatomic distribution of cancers and colorectal adenomas according to age and sex and relationship between proximal and distal neoplasms in an i-FOBT-positive average-risk Italian screening cohortPrecut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone diseaseCorrelation between oropharyngeal pH-monitoring and esophageal pH-impedance monitoring in patients with suspected GERD-related extra-esophageal symptoms2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipationHigh-definition with i-Scan gives comparable accuracy for detecting colonic lesions by non-expert and expert endoscopistspH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian seriesPancreatic pseudotumor caused by toothpick ingestionAn Unusual Case of Right Lower Abdominal Pain
P50
Q34161463-92022780-2258-4212-A119-85B05C571AF4Q43107859-4A63A56F-B6AB-4B2F-BC7D-BDD487C78761Q43534392-01AE897D-F4FB-4967-8B4C-CAC8DE6ACC1CQ45188491-ED809915-F965-42E8-B80F-E025BF6901D1Q46325160-F265682C-709B-42CD-A93A-5D57AE48576CQ48518805-B1AD5D7A-5410-4817-A6B2-74A0DF8C15D4Q48905445-D1FC13EC-E7F6-449B-8763-2B0EC44DD789Q57971888-604EEED8-3950-438A-94EC-529BB1D23AEFQ84512840-4948FD14-37B0-4D12-9D87-BC6C9F7B7167Q85289797-0C120A2E-6B61-49D3-82D7-CE34C6652053Q85692452-F8E7118D-0A95-4176-92B4-C9198F2F2BAFQ86043234-6F0FEB61-F4C1-4A3E-8A60-207F05AAA72AQ86931550-D2E2C177-F59E-4CF5-A71F-86467838BABBQ87053787-A1D596BB-7003-4A72-AC28-47453BCE11D2Q87816730-D69DA0E1-FF1C-4F57-A476-924310E8F38E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cristian Vailati
@ast
Cristian Vailati
@en
Cristian Vailati
@es
Cristian Vailati
@nl
type
label
Cristian Vailati
@ast
Cristian Vailati
@en
Cristian Vailati
@es
Cristian Vailati
@nl
prefLabel
Cristian Vailati
@ast
Cristian Vailati
@en
Cristian Vailati
@es
Cristian Vailati
@nl
P106
P1153
22942502900
P21
P31
P496
0000-0002-7633-9436